HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ

BACKGROUND: Ductal carcinoma in situ (DCIS) is a non-invasive form of breast cancer that may progress to invasive cancer. Identification of factors that predict recurrence and distinguish DCIS from invasive recurrence would facilitate treatment recommendations. We examined the prognostic value of ni...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Rakovitch, E, Nofech-Mozes, S, Hanna, W, Narod, S, Thiruchelvam, D, Saskin, R, Spayne, J, Taylor, C, Paszat, L
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2012
Sujets:
Molecular Diagnostics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3304413/
https://ncbi.nlm.nih.gov/pubmed/22361634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2012.41
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires